XML 41 R25.htm IDEA: XBRL DOCUMENT v3.25.1
Income Taxes (Tables)
12 Months Ended
Dec. 31, 2024
Income Tax Disclosure [Abstract]  
Schedule of Components of Deferred Tax Assets
   2024   2023 
   December 31, 
   2024   2023 
Research credits  $652,000   $612,000 
Capitalized research and development   900,000    844,000 
Stock-based compensation   1,550,000    1,631,000 
Net operating loss carryforwards   9,515,000    8,601,000 
Total deferred tax assets   12,617,000    11,688,000 
Valuation allowance   (12,617,000)   (11,688,000)
Net deferred tax assets  $   $ 
Schedule of Effective Income Tax Rate
   2024   2023 
   Years Ended December 31, 
   2024   2023 
         
U. S. federal statutory tax rate   (21.0)%   (21.0)%
State income taxes, net of federal tax benefit   (6.0)%   (6.0)%
Expirations related to stock-based compensation   3.8%   10.4%
Adjustment to deferred tax asset   (1.1)%   (0.8)%
Change in valuation allowance   24.3%   17.4%
Effective tax rate   0.0%   0.0%